1 / 8

Rivaroxaban Market To Surpass US$ 7.0 Billion By 2026 - Coherent Market Insights

u201cCoherent Market Insights u201cRIVAROXABAN MARKET u2013 GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027u2033

SANJAYCMI
Download Presentation

Rivaroxaban Market To Surpass US$ 7.0 Billion By 2026 - Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RIVAROXABAN MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Rivaroxaban Market - Overview The Global Rivaroxaban Market, by Strength (10 mg, 15 mg, and 20 mg), by Application (Deep Vein Thrombosis Prophylaxis and Pulmonary Embolism), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 5,653 million in 2017 and is projected to exhibit a CAGR of 1.5% over the forecast period (2018 – 2026). The API patent is set to expire in 2020 and product patent in 2023 leading to anticipated price erosion if the drug. Rivaroxaban is an oral anticoagulant, which was developed by Bayer and sold under the brand name Xarelto. The drug is indicated for the treatment of deep vein thrombosis prophylaxis or pulmonary embolism and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). The drug is marketed by Bayer outside the U.S. and in the U.S., it is marketed by Janssen Pharmaceuticals, Inc. Xarelto is among the most popular anticoagulants, which includes brands like Caumadin, Praxada, and Eliquis. The trajectory growth of rivaroxaban market can be attributed to increasing clinical trials by companies and universities to expand the indication of the drug or to use in combination with other drug. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/rivaroxaban-market-1962 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Browse Market Data 22 Tables and 20 Figures spread through 150 Pages and in- depth TOC on ‘Rivaroxaban Market, by Strength (10 mg, 15 mg, and 20 mg), by Application (Deep Vein Thrombosis Prophylaxis and Pulmonary Embolism), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region - Global Forecast to 2026’ To know the latest trends and insights related to rivaroxaban market, The market players of rivaroxaban market are also concentrating on enhancing effectiveness and reducing the side effects such as bleeding of the drug. For instance, as of June 2018, Janssen Scientific Affairs, LLC is studying the effectiveness of Xarelto with a mobile adherence platform, to improve medication adherence in patients with atrial fibrillation. However, the presence of cheaper alternative drugs such as warfarin, apixaban, and dabigatran are expected to be major factors hindering the rivaroxaban market growth. The treatment cost using warfarin is as low as US$ 4 per month whereas the cost of rivaroxaban is around US$ 450 per month. This vast difference in cost of the drug lead the patients towards adopting cheaper alternative, thereby negatively affecting the market growth. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/1962 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Key takeaways of the Rivaroxaban Market: The global rivaroxaban market is expected to expand at a CAGR of 1.5% over the forecast period (2018 – 2026), owing to increasing clinical trials High cost of rivaroxaban therapy compared to it alternatives may restrain the market growth Patent expiration leading to manufacturing of generics is expected to pose challenge to the Xarelto brand and may result in price reduction Some of the major players operating in the global rivaroxaban market include Janssen Pharmaceuticals Inc. and Bayer AG. For instance, the University Hospital Inselspital, Berne, in collaboration with Bayer and Janssen, and two others, are studying the efficacy of rivaroxaban in patients undergoing bariatric surgery and as on May 2018, the trial was under phase II. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1962 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related